[1]
I. V. . Bushuieva, K. V. Petrova, B. P. . Kyrychko, and V. V. Parchenko, “Study of mutagenic effects with predicted carcinogenicity of 4-((5-decylthio)-4-methyl-4-H-1,2,4-triazole-3-yl)methyl)morpholine for further research in order to create a new drug with antifungal activity”, Current issues in pharmacy and medicine: science and practice, vol. 15, no. 3, pp. 271–276, Nov. 2022.